Cargando…
Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment
BACKGROUND: An early virological response (EVR) after the start of interferon (IFN) treatment for chronic hepatitis C leads to a successful virological outcome. To analyze an association between sustained virological response (SVR) and EVR by comparing TaqMan with Amplicor assays in HCV genotype 1-i...
Autores principales: | Ogawa, Eiichi, Furusyo, Norihiro, Toyoda, Kazuhiro, Taniai, Hiroaki, Otaguro, Shigeru, Kainuma, Mosaburo, Murata, Masayuki, Sawayama, Yasunori, Hayashi, Jun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873600/ https://www.ncbi.nlm.nih.gov/pubmed/20398383 http://dx.doi.org/10.1186/1471-230X-10-38 |
Ejemplares similares
-
A case report of human immunodeficiency virus-associated anaplastic lymphoma kinase protein-negative anaplastic large cell lymphoma
por: Taniai, Hiroaki, et al.
Publicado: (2013) -
Cobas Ampliprep/Cobas TaqMan HIV-1 v2.0 Assay: Consequences at the Cohort Level
por: Taylor, Ninon, et al.
Publicado: (2013) -
Performance evaluation of the DAAN HCV assay for quantification of hepatitis C virus RNA and its comparison with COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, v2.0
por: He, Yuting, et al.
Publicado: (2020) -
Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0
por: Worlock, A., et al.
Publicado: (2017) -
Clinical Evaluation of COBAS TaqMan PCR for the Detection of Mycobacterium tuberculosis and M. avium Complex
por: Ikegame, Satoshi, et al.
Publicado: (2012)